[1] OGURTSOVA K, DA ROCHA FERNANDES JD, HUANG Y, et al.IDF Diabetes Atlas:Global estimates for the prevalence of diabetes for 2015 and 2040[J].Diabetes Res Clin Pract, 2017, 128:40.
[2] 徐枫, 朱剑峰, 董晓维, 等.上海市某社区338例糖尿病患者眼部并发症筛查结果分析[J].中华疾病控制杂志, 2011, 15(5):401.
[3] CHEUNG N, MITCHELL P, WONG TY.Diabetic retinopathy[J].Lancet, 2010, 376(9735):124.
[4] 惠延年, 王琳.糖尿病视网膜病变和黄斑水肿的国际临床分类法[J].国际眼科杂志, 2004, 2(1):56.
[5] SONG P, YU J, CHAN KY, et al.Prevalence, risk factors and burden of diabetic retinopathy in China:a systematic review and meta-analysis[J].J Glob Health, 2018, 8(1):010803.
[6] PAN CW, WANG S, QIAN DJ, et al.Prevalence, awareness, and risk factors of diabetic retinopathy among adults with known type 2 diabetes mellitus in an urban community in China[J].Ophthalmic Epidemiol, 2017, 24(3):188.
[7] CUI J, REN JP, CHEN DN, et al.Prevalence and associated factors of diabetic retinopathy in Beijing, China:a cross-sectional study[J].BMJ Open, 2017, 7(8):e015473.
[8] PANG C, JIA L, JIANG S, et al.Determination of diabetic retinopathy prevalence and associated risk factors in Chinese diabetic and pre-diabetic subjects:Shanghai diabetic complications study[J].Diabetes Metab Res Rev, 2012, 28(3):276.
[9] 张敏, 崔颖, 孟倩丽, 等.广东省东莞市糖尿病视网膜病变流行病学调查[J].眼科新进展, 2014, 34(3):260.
[10] YAU JW, ROGERS SL, KAWASAKI R, et al.Global prevalence and major risk factors of diabetic retinopathy[J].Diabetes Care, 2012, 35(3):556.
[11] CHA AE, VILLARROEL MA, VAHRATIAN A.Eye disorders and vision loss among U.S.adults aged 45 and over with diagnosed diabetes, 2016-2017[J].NCHS Data Brief, 2019(344):1.
[12] AFROZ A, ZHANG W, WEI LOH AJ, et al.Macro-and micro-vascular complications and their determinants among people with type 2 diabetes in Bangladesh[J].Diabetes Metab Syndr, 2019, 13(5):2939.
[13] MAJITHIA S, THAM YC, CHEE ML, et al.Singapore Chinese Eye Study:key findings from baseline examination and the rationale, methodology of the 6-year follow-up series[J].Br J Ophthalmol, 2019, pii:bjophthalmol-2019-314760.
[14] KUMARI N, BHARGAVA M, NGUYEN DQ, et al.Six-year incidence and progression of diabetic retinopathy in Indian adults:the Singapore Indian Eye study[J].Br J Ophthalmol, 2019, 103(12):1732.
[15] WONG TY, SABANAYAGAM C.Strategies to tackle the global burden of diabetic retinopathy:from epidemiology to artificial intelligence[J].Ophthalmologica, 2020, 243(1):9.
[16] ALJIED R, AUBIN MJ, BUHRMANN R, et al.Visual impairment and the use of formal and informal home care in Canada:the Canadian Longitudinal Study on Aging[J].Can J Ophthalmol, 2019, 54(3):367.
[17] BARBARESKO J, NEUENSCHWANDER M, SCHWINGSHACKL L, et al.Dietary factors and diabetes-related health outcomes in patients with type 2 diabetes:protocol for a systematic review and meta-analysis of prospective observational studies[J].BMJ Open, 2019, 9(7):e027298.
[18] WANG J, BROWN C, SHI C, et al.Improving diabetic and hypertensive retinopathy with a medical food containing L-methylfolate:a preliminary report[J].Eye Vis (Lond), 2019, 6:21.
[19] WAN H, WANG Y, ZHANG K, et al.Associations between vitamin D and microvascular complications in middle-aged and elderly diabetic patients[J].Endocr Pract, 2019, 25(8):809.
[20] ZHANG G, CHEN H, CHEN W, et al.Prevalence and risk factors for diabetic retinopathy in China:a multi-hospital-based cross-sectional study[J].Br J Ophthalmol, 2017, 101(12):1591.
[21] JIN G, XIAO W, DING X, et al.Prevalence of and risk factors for diabetic retinopathy in a rural Chinese population:the Yangxi Eye Study[J].Invest Ophthalmol Vis Sci, 2018, 59(12):5067.
[22] 张建文, 马丽, 马凤仙.糖尿病视网膜病变发生发展的相关因素分析[J].国际眼科杂志, 2013, 13(11):2262.
[23] EID S, SAS KM, ABCOUWER SF, et al.New insights into the mechanisms of diabetic complications:role of lipids and lipid metabolism[J].Diabetologia, 2019, 62(9):1539.
[24] LARSEN MB, HENRIKSEN JE, GRAUSLUND J, et al.Prevalence and risk factors for diabetic retinopathy in 17152 patients from the island of Funen, Denmark[J].Acta Ophthalmol, 2017, 95(8):778. doi: 10.1111/aos.13449
[25] ZHUANG X, CAO D, YANG D, et al.Association of diabetic retinopathy and diabetic macular oedema with renal function in southern Chinese patients with type 2 diabetes mellitus:a single-centre observational study[J].BMJ Open, 2019, 9(9):e031194.
[26] 王佳.糖尿病性视网膜病变与糖尿病性黄斑水肿相关性的病例分析[D].合肥: 安徽医科大学, 2013.
[27] 林娜.糖尿病视网膜病变与黄斑水肿相关性分析[J].内蒙古医学杂志, 2015, 47(5):599.
[28] DAI W, THAM YC, CHEUNG N, et al.Macular thickness profile and diabetic retinopathy:the Singapore Epidemiology of Eye Diseases Study[J].Br J Ophthalmol, 2018, 102(8):1072.